Zolmitriptan Patent Expiration
Zolmitriptan was first introduced by Ipr Pharmaceuticals Inc
Zolmitriptan Patents
Given below is the list of patents protecting Zolmitriptan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zomig | US5466699 | Indolyl compounds for treating migraine |
Nov 14, 2012
(Expired) | Amneal |
| Zomig | US5466699 | Indolyl compounds for treating migraine |
Nov 14, 2012
(Expired) | Ipr |
| Zomig |
US5466699 (Pediatric) | Indolyl compounds for treating migraine |
May 14, 2013
(Expired) | Amneal |
| Zomig |
US5466699 (Pediatric) | Indolyl compounds for treating migraine |
May 14, 2013
(Expired) | Ipr |
| Zomig | US5863935 | Therapeutic heterocyclic compounds |
Nov 14, 2012
(Expired) | Ipr |
| Zomig |
US5863935 (Pediatric) | Therapeutic heterocyclic compounds |
May 14, 2013
(Expired) | Ipr |
| Zomig | US6750237 | Pharmaceutical formulations containing zolmitriptan |
Nov 28, 2020
(Expired) | Amneal |
| Zomig |
US6750237 (Pediatric) | Pharmaceutical formulations containing zolmitriptan |
May 28, 2021
(Expired) | Amneal |
| Zomig | US7220767 | Pharmaceutical formulations containing zolmitriptan |
Nov 28, 2020
(Expired) | Amneal |
| Zomig |
US7220767 (Pediatric) | Pharmaceutical formulations containing zolmitriptan |
May 28, 2021
(Expired) | Amneal |
| Zomig-zmt | US5466699 | Indolyl compounds for treating migraine |
Nov 14, 2012
(Expired) | Astrazeneca |
| Zomig-zmt |
US5466699 (Pediatric) | Indolyl compounds for treating migraine |
May 14, 2013
(Expired) | Astrazeneca |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Zolmitriptan's patents.
Latest Legal Activities on Zolmitriptan's Patents
Given below is the list recent legal activities going on the following patents of Zolmitriptan.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Nov, 2018 | US7220767(Litigated) |
| Request for Trial Denied Critical | 02 Feb, 2016 | US7220767(Litigated) |
| Request for Trial Denied Critical | 27 Jan, 2016 | US6750237(Litigated) |
| Recordation of Patent Grant Mailed Critical | 22 May, 2007 | US7220767(Litigated) |
| Patent Issue Date Used in PTA Calculation Critical | 22 May, 2007 | US7220767(Litigated) |
| Issue Notification Mailed Critical | 02 May, 2007 | US7220767(Litigated) |
| Dispatch to FDC | 19 Apr, 2007 | US7220767(Litigated) |
| Issue Fee Payment Received Critical | 18 Apr, 2007 | US7220767(Litigated) |
| Application Is Considered Ready for Issue Critical | 18 Apr, 2007 | US7220767(Litigated) |
| Issue Fee Payment Verified Critical | 18 Apr, 2007 | US7220767(Litigated) |
Try Our Curated Drug Screens
Zolmitriptan Generics
Several generic applications have been filed for Zolmitriptan. The first generic version for Zolmitriptan was by Glenmark Pharmaceuticals Ltd and was approved on May 14, 2013. And the latest generic version is by Padagis Israel Pharmaceuticals Ltd and was approved on Sep 30, 2021.
Given below is the list of companies who have filed for Zolmitriptan generic.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | May 20, 2016 |
| 5MG
(reference standard) | tablet | Prescription | ORAL | AB | May 20, 2016 |
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Dec 1, 2016 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Dec 1, 2016 |
3. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Mar 4, 2014 |
| 5MG | tablet | Discontinued | ORAL | N/A | Mar 4, 2014 |
4. APOTEX INC
Apotex Inc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | May 14, 2013 |
| 5MG | tablet | Discontinued | ORAL | N/A | May 14, 2013 |
5. APPCO
Appco Pharma Llc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Appco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Jun 30, 2017 |
| 2.5MG | tablet | Prescription | ORAL | AB | Jun 30, 2017 |
6. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | May 11, 2016 |
| 5MG | tablet | Prescription | ORAL | AB | May 11, 2016 |
7. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | May 14, 2013 |
| 2.5MG | tablet | Prescription | ORAL | AB | May 14, 2013 |
8. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 9, 2014 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Apr 9, 2014 |
9. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Sep 17, 2015 |
| 2.5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Sep 17, 2015 |
10. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Oct 22, 2015 |
| 2.5MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Oct 22, 2015 |
11. NATCO PHARMA USA
Natco Pharma Usa Llc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Natco Pharma Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | May 14, 2013 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | May 14, 2013 |
12. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Oct 21, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB | Oct 21, 2019 |
13. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG/SPRAY | spray | Prescription | NASAL | AB | Sep 30, 2021 |
| 5MG/SPRAY
(reference standard) | spray | Prescription | NASAL | AB | Sep 30, 2021 |
14. PLD ACQUISITIONS LLC
Pld Acquisitions Llc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Pld Acquisitions Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | Feb 27, 2017 |
| 5MG | tablet | Prescription | ORAL | AB | Feb 27, 2017 |
15. RISING
Rising Pharma Holding Inc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Sep 20, 2019 |
| 2.5MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Sep 20, 2019 |
16. SUN PHARMA GLOBAL
Sun Pharma Global Fze has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Sun Pharma Global.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Nov 13, 2014 |
| 5MG | tablet | Discontinued | ORAL | N/A | Nov 13, 2014 |
17. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Jul 11, 2018 |
| 2.5MG | tablet | Prescription | ORAL | AB | Jul 11, 2018 |
18. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Zolmitriptan. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 15, 2013 |
| 5MG
(reference standard) | tablet, orally disintegrating | Prescription | ORAL | AB | May 15, 2013 |